688581 Stock Overview
Engages in the research, development, production, sale, and service of endoscopic surgery equipment and accessories in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for 688581 from our risk checks.
Hangzhou AGS MedTech Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥63.70 |
| 52 Week High | CN¥91.76 |
| 52 Week Low | CN¥42.92 |
| Beta | 0 |
| 11 Month Change | 6.33% |
| 3 Month Change | 34.67% |
| 1 Year Change | -22.80% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -28.25% |
Recent News & Updates
Recent updates
An Intrinsic Calculation For Hangzhou AGS MedTech Co., Ltd. (SHSE:688581) Suggests It's 43% Undervalued
Oct 25
There May Be Underlying Issues With The Quality Of HangzhouS MedTech's (SHSE:688581) Earnings
Apr 29Hangzhou AGS MedTech Co., Ltd. (SHSE:688581) Looks Inexpensive But Perhaps Not Attractive Enough
Apr 24Shareholder Returns
| 688581 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | 2.7% | -2.4% | -3.4% |
| 1Y | -22.8% | -5.5% | 6.1% |
Return vs Industry: 688581 underperformed the CN Medical Equipment industry which returned -5.5% over the past year.
Return vs Market: 688581 underperformed the CN Market which returned 6.1% over the past year.
Price Volatility
| 688581 volatility | |
|---|---|
| 688581 Average Weekly Movement | 7.4% |
| Medical Equipment Industry Average Movement | 8.5% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.5% |
Stable Share Price: 688581 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688581's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 672 | Cheng Zhang | www.bioags.com |
Hangzhou AGS MedTech Co., Ltd. engages in the research, development, production, sale, and service of endoscopic surgery equipment and accessories in China. It offers hemoclips; bipolar generators, CR4500 CO2 regulation units, and UW600-II water pumps; disposable stone extraction baskets, nasal biliary drainage catheters, sphincterotomes, disposable guide wires, and stone retrieval balloons; disposable bipolar ESD knives, polypectomy snares, and disposable sclerotherapy needles; and disposable grasping forceps and disposable biopsy forceps. The company was founded in 2010 and is based in China.
Hangzhou AGS MedTech Co., Ltd. Fundamentals Summary
| 688581 fundamental statistics | |
|---|---|
| Market cap | CN¥5.14b |
| Earnings (TTM) | CN¥271.52m |
| Revenue (TTM) | CN¥590.12m |
18.9x
P/E Ratio8.7x
P/S RatioIs 688581 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688581 income statement (TTM) | |
|---|---|
| Revenue | CN¥590.12m |
| Cost of Revenue | CN¥162.79m |
| Gross Profit | CN¥427.34m |
| Other Expenses | CN¥155.82m |
| Earnings | CN¥271.52m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.37 |
| Gross Margin | 72.41% |
| Net Profit Margin | 46.01% |
| Debt/Equity Ratio | 0% |
How did 688581 perform over the long term?
See historical performance and comparison